文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

阿托伐他汀对急性主动脉夹层患者住院死亡率影响的随机对照试验方案

Efficiency of atorvastatin on in-hospital mortality of patients with acute aortic dissection (AAD): study protocol for a randomized, open-label, superiority clinical trial.
PubMed 文献 · Trials · 2021-04-14

本研究为随机、开放标签、优效性临床试验方案,计划在汕头大学医学院第一附属医院招募384例急性主动脉夹层患者,随机分为阿托伐他汀治疗组与对照组,主要结局为30天住院死亡率,旨在验证阿托伐他汀能否降低此类患者住院死亡率。

要点

  • 拟纳入384例急性主动脉夹层患者,随机分组比较阿托伐他汀与对照。
  • 主要结局为30天住院死亡率。
  • 研究注册号ChiCTR1900023515,注册日期2019年6月1日。

核心结论

  • 该研究旨在验证阿托伐他汀降低急性主动脉夹层患者住院死亡率的效果,为常规药物治疗提供补充手段。

研究设计与样本

  • 随机、开放标签、优效性临床试验方案,计划在汕头大学医学院第一附属医院招募384例急性主动脉夹层患者,随机分为阿托伐他汀治疗组和对照组。

关键数值与推荐

  • 主要结局为30天住院死亡率。
  • 试验注册于中国临床试验注册中心,注册号ChiCTR1900023515,注册日期2019年6月1日。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dyslipidemia and local inflammation at sites of lipid deposition on blood vessel walls have been demonstrated to be risk factors for patients with acute aortic dissection (AAD). Statins have anti-inflammatory and lipid-lowering effects, which suggest that statins may play an important role in the prevention and treatment of AAD. Some retrospective studies show that statins can protect patients with aortic dissection. However, the effect of statins on the survival of AAD patients has been scarcely investigated, especially in randomized trials. In this study, we will perform a randomized clinical trial to understand whether statins can reduce in-hospital mortality of AAD patients. METHODS: A total of 384 subjects diagnosed with AAD in the First Affiliated Hospital of Shantou University Medical College will be recruited. Participants will be randomly divided into an atorvastatin-treated or control group. The primary outcome will be the in-hospital mortality at 30 days. DISCUSSION: This study is designed to verify the efficacy of atorvastatin on reducing in-hospital mortality of patients with AAD. The aim is to provide a new means of improving survival as a complement to conventional drug therapy. TRIAL REGISTRATION: Chinese Clinical Trials Registry ChiCTR1900023515 . Registered on 1 June 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chen Y, Xiong N, Wang X, et al. Efficiency of atorvastatin on in-hospital mortality of patients with acute aortic dissection (AAD): study protocol for a randomized, open-label, superiority clinical trial. Trials. 2021. PMID: 33853639. doi:10.1186/s13063-021-05237-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。